Two health innovations we launched in 2021

In 2021, we launched two innovations:

• X-Pure®, GelDAT® 
  Launched in May ‘21
  A highly purified gelatin from the X-Pure range, GelDAT® is ideal for research and preclinical development in regenerative medicine, drug release, cell culture, and complex wound dressings.

• Quali-Pure®
  Launched in October ‘21
  With controlled endotoxin levels, Quali-Pure can support biomedical applications, like embolization, wound healing, drug delivery, vaccines, and hemostatics. It will help medical devices manufacturers to comply with new the Medical Device Regulation (MDR) in May 2024.

Our ESG goals are aligned with the United Nation’s 3rd Sustainable Development Goal (SDG): ‘to ensure healthy lives and promote well-being for all at all ages’.